Cargando…

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma

The intimate interaction between redox signaling and immunity has been widely revealed. However, the clinical application of relevant therapeutic is unavailable due to the absence of validated markers that stratify patients. Here, we identified novel biomarkers for prognosis prediction in hepatocell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Kangsheng, Li, Jin, Mo, Huanye, Xian, Yao, Xu, Qiuran, Xiao, Xuelian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040390/ https://www.ncbi.nlm.nih.gov/pubmed/33850474 http://dx.doi.org/10.7150/ijms.56289

Ejemplares similares

Long noncoding RNA FIRRE contributes to the proliferation and glycolysis of hepatocellular carcinoma cells by enhancing PFKFB4 expression
por: Shen, Cunyi, et al.
Publicado: (2021)

A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
por: Li, Yue, et al.
Publicado: (2022)

Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma
por: Li, Yue, et al.
Publicado: (2022)

Long noncoding RNA PICSAR/miR‐588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway
por: Liu, Zhikui, et al.
Publicado: (2020)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Correction to: Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2022)

Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B
por: Wang, Jianjiang, et al.
Publicado: (2021)

Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression
por: Wang, Jun, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)

MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
por: Wang, Liang, et al.
Publicado: (2021)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Establishment and Validation of a Peroxisome-related Gene Signature for Prognostic Prediction and Immune Distinction in Hepatocellular Carcinoma
por: Miao, Dan, et al.
Publicado: (2022)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma
por: Yan, Hongmei, et al.
Publicado: (2020)

HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
por: Chen, Tianxiang, et al.
Publicado: (2021)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma
por: Fu, Xiao-Wei, et al.
Publicado: (2021)

Developing and Validating an Autophagy Gene-Set-Based Prognostic Signature in Hepatocellular Carcinoma Patients
por: Zhang, Jie, et al.
Publicado: (2022)

Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma
por: Wu, Guozhi, et al.
Publicado: (2022)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
por: Yan, Yongcong, et al.
Publicado: (2019)

Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
por: Ren, Jie, et al.
Publicado: (2021)

Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway
por: Dou, Changwei, et al.
Publicado: (2020)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma
por: Feng, Xiaofei, et al.
Publicado: (2021)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma
por: Li, Chao, et al.
Publicado: (2014)

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma
por: Qin, Rujia, et al.
Publicado: (2021)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iu8lk7cfkof9b2g6bk1on6d7gl